- Published at
- by gurufocus.com
neutral
neutral
Faron Pharmaceuticals Oy (FRA:4FR) Full Year 2024 Earnings Call Highlights: Financial Gains and Strategic Advances Amid Challenges
Cash Position: Ended 2024 with EUR9.5 million, up from around EUR7 million the previous year.Gross Fundraising: Raised EUR35.5 million through a combined trans